Abstract
Objective
Current therapies often have limited efficacy and untenable side effects when used to treat persistent incisional pain following cancer-related surgery. Lidocaine patches reduce neuropathic pain from herpes zoster but their benefits for persistent cancer-related postsurgical incisional pain remain unclear.
Study design
Multicenter, double-blind, randomized, two-period crossover trial.
Materials and methods
Twenty-eight cancer patients with postsurgical incisional pain were randomly assigned to receive either lidocaine patches followed by placebo patches or the reverse. Each study period lasted 4 weeks. Patches were applied daily upon waking and left in place for a maximum of 18 h. The primary outcome measure, an 11-point pain intensity rating scale, was administered weekly. Secondary outcomes were administered weekly (Brief Pain Inventory-Short Form(BPI-SF), Subject Global Impression of Change) and at the end of each study period (Short Form-Magill Pain Questionnaire, Linear Analogue Self Assessment Scale, Neuropathy Pain Scale, Pain Catastrophizing Scale, Profile of Mood States Short Form).
Results
Twenty-one patients completed the first period and 18 completed their crossover second phase. No significant intergroup differences were detected in pain intensity ratings. Few secondary end points were significantly different when subjects used the lidocaine versus placebo patches. BPI-SF interference scores were lower in patients using the lidocaine patch during the first study period, including several scores that achieved statistical significance, general activity (p = 0.02), work (p = 0.04), and relations with others (p = 0.02).
Conclusion
Lidocaine patch use did not significantly reduce pain intensity ratings or the majority of related secondary end points in cancer patients with persistent incisional pain.
Similar content being viewed by others
References
Argoff CE (2004) Conclusions: chronic pain studies of lidocaine patch 5% using the Neuropathic Pain Scale. Curr Med Res Opin 20(Suppl 2):S29–S31. doi:10.1185/030079904X12979
Baker F, Denniston M, Zabora J, Polland A, Dudley WN (2002) A POMS short form for cancer patients: psychometric and structural evaluation. Psychooncology 11:273–281. doi:10.1002/pon.564
Begg C, Cho M, Eastwood S, Horton R, Moher D, Olkin I, Pitkin R, Rennie D, Schulz KF, Simel D, Stroup DF (1996) Improving the quality of reporting of randomized controlled trials. The CONSORT statement. JAMA 276:637–639. doi:10.1001/jama.276.8.637
Campbell JN, Raja SN, Meyer RA, Mackinnon SE (1988) Myelinated afferents signal the hyperalgesia associated with nerve injury. Pain 32:89–94. doi:10.1016/0304-3959(88)90027-9
Cleeland C et al (1992) How to assess cancer pain. In: Turk DC, Melzack R (eds) Handbook of pain assessment. Guilford, New York, pp 360–387
Coderre TJ, Katz J, Vaccarino AL, Melzack R (1993) Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 52:259–285. doi:10.1016/0304-3959(93)90161-H
Dajczman E, Gordon A, Kreisman H, Wolkove N (1991) Long-term postthoracotomy pain. Chest 99:270–274. doi:10.1378/chest.99.2.270
Dworkin RH, Corbin AE, Young JP Jr, Sharma U, LaMoreaux L, Bockbrader H, Garofalo EA, Poole RM (2003) Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo-controlled trial. Neurology 60:1274–1283
Fairclough DPH, Cella D, Bonomi P (1998) Comparison of several model-based methods for analyzing incomplete quality of life data in cancer trials. Stat Med 17:781–796. doi:10.1002/(SICI)1097-0258(19980315/15)17:5/7<781::AID-SIM821>3.0.CO;2-O
Farrar JT, Young JP Jr, LaMoreaux L, Werth JL, Poole RM (2001) Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 94:149–158. doi:10.1016/S0304-3959(01)00349-9
Galer BS, Rowbotham MC, Perander J, Friedman E (1999) Topical lidocaine patch relieves postherpetic neuralgia more effectively than a vehicle topical patch: results of an enriched enrollment study. Pain 80:533–538. doi:10.1016/S0304-3959(98)00244-9
Galer BS, Jensen MP, Ma T, Davies PS, Rowbotham MC (2002) The lidocaine patch 5% effectively treats all neuropathic pain qualities: results of a randomized, double-blind, vehicle-controlled, 3-week efficacy study with use of the neuropathic pain scale. Clin J Pain 18:297–301. doi:10.1097/00002508-200209000-00004
Gammaitoni AR, Alvarez NA, Galer BS (2003) Safety and tolerability of the lidocaine patch 5%, a targeted peripheral analgesic: a review of the literature. J Clin Pharmacol 43:111–117. doi:10.1177/0091270002239817
Hurny C, Bernhard J, Coates A, Peterson HF, Castiglione-Gertsch M, Gelber RD, Rudenstam CM, Collins J, Lindtner J, Goldhirsch A, Senn HJ (1996) Responsiveness of a single-item indicator versus a multi-item scale: assessment of emotional well-being in an international adjuvant breast cancer trial. Med Care 34:234–248. doi:10.1097/00005650-199603000-00004
Jensen MP, Karoly P, Braver S (1986) The measurement of clinical pain intensity: a comparison of six methods. Pain 27:117–126. doi:10.1016/0304-3959(86)90228-9
Jensen MP, Dworkin RH, Gammaitoni AR, Olaleye DO, Oleka N, Galer BS (2005) Assessment of pain quality in chronic neuropathic and nociceptive pain clinical trials with the Neuropathic Pain Scale. J Pain 6:98–106. doi:10.1016/j.jpain.2004.11.002
Johansson A, Kornfalt J, Nordin L, Svensson L, Ingvar C, Lundberg J (2003) Wound infiltration with ropivacaine and fentanyl: effects on postoperative pain and PONV after breast surgery. J Clin Anesth 15:113–118. doi:10.1016/S0952-8180(02)00511-1
Karmakar MK, Ho AM (2004) Postthoracotomy pain syndrome. Thorac Surg Clin 14:345–352. doi:10.1016/S1547-4127(04)00022-2
Katz J, McCartney CJ (2002) Current status of pre-emptive analgesia. Curr Opin Anaesthesiol 15:435–441. doi:10.1097/00001503-200208000-00005
Kehlet H, Jensen TS, Woolf CJ (2006) Persistent postsurgical pain: risk factors and prevention. Lancet 367:1618–1625. doi:10.1016/S0140-6736(06)68700-X
Loprinzi CL, Kugler JW, Sloan JA, Rooke TW, Quella SK, Novotny P, Mowat RB, Michalak JC, Stella PJ, Levitt R, Tschetter LK, Windschitl H (1999) Lack of effect of coumarin in women with lymphedema after treatment for breast cancer. N Engl J Med 340:346–350. doi:10.1056/NEJM199902043400503
Lussier D, Huskey AG, Portenoy RK (2004) Adjuvant analgesics in cancer pain management. Oncologist 9:571–591. doi:10.1634/theoncologist.9-5-571
Macdonald L, Bruce J, Scott NW, Smith WC, Chambers WA (2005) Long-term follow-up of breast cancer survivors with post-mastectomy pain syndrome. Br J Cancer 92:225–230
Malenka RC (1991) The role of postsynaptic calcium in the induction of long-term potentiation. Mol Neurobiol 5:289–295. doi:10.1007/BF02935552
Mandrekar JSD, Novotny PJ, Slaon JA (1999) A general Gibbs sampling algorithm for analyzing linear models using the SAS system. In: Proceedings of the SUGI, p 1644–1649
Mandrekar JSD, Novotny PJ, Slaon JA (1999) A general Gibbs sampling algorithm for analyzing linear models using the SAS system. SUGI Proc 24:1644–1649
Melzack R (1975) The McGill Pain Questionnaire: major properties and scoring methods. Pain 1:277–299. doi:10.1016/0304-3959(75)90044-5
Melzack R (1987) The short-form McGill pain questionnaire. Pain 30:191–197. doi:10.1016/0304-3959(87)91074-8
Nguyen A, Girard F, Boudreault D, Fugere F, Ruel M, Moumdjian R, Bouthilier A, Caron JL, Bojanowski MW, Girard DC (2001) Scalp nerve blocks decrease the severity of pain after craniotomy. Anesth Analg 93:1272–1276. doi:10.1097/00000539-200111000-00048
Osman A, Barrios FX, Kopper BA, Hauptmann W, Jones J, O’Neill E (1997) Factor structure, reliability, and validity of the Pain Catastrophizing Scale. J Behav Med 20:589–605. doi:10.1023/A:1025570508954
Pergolizzi J, Boger RH, Budd K, Dahan A, Erdine S, Hans G, Kress HG, Langford R, Likar R, Raffa RB, Sacerdote P (2008) Opioids and the management of chronic severe pain in the elderly: consensus statement of an International Expert Panel with focus on the six clinically most often used World Health Organization step III opioids (buprenorphine, fentanyl, hydromorphone, methadone, morphine, oxycodone). Pain Pract 8:287–313. doi:10.1111/j.1533-2500.2008.00204.x
Pocock SJ, Simon R (1975) Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial. Biometrics 31:103–115. doi:10.2307/2529712
Reuben SS (2007) Chronic pain after surgery: what can we do to prevent it. Curr Pain Headache Rep 11:5–13. doi:10.1007/s11916-007-0015-9
Rowbotham MC, Davies PS, Verkempinck C, Galer BS (1996) Lidocaine patch: double-blind controlled study of a new treatment method for post-herpetic neuralgia. Pain 65:39–44. doi:10.1016/0304-3959(95)00146-8
Senn S (1993) Cross-over trials in clinical research. Wiley, New York
Sloan JA, Dueck A (2004) Issues for statisticians in conducting analyses and translating results for quality of life end points in clinical trials. J Biopharm Stat 14:73–96. doi:10.1081/BIP-120028507
Sloan JANP, Lorinzi CL, Nair S (1997) Graphical and analytical tools for the analysis two-period crossover clinical trials. SUGI Proc 22:1312–1317
Sloan JA OFJ, Suman VJ, Sargeant DJ (1998) Incorporating quality of life measurement in oncology clinical trials. In: Proceedings of the American Statistical Association, p 281–287
Wallace MS, Wallace AM, Lee J, Dobke MK (1996) Pain after breast surgery: a survey of 282 women. Pain 66:195–205. doi:10.1016/0304-3959(96)03064-3
Wiffen PJ, McQuay HJ, Edwards JE, Moore RA (2005) Gabapentin for acute and chronic pain. Cochrane Database Syst Rev CD005452
Wiffen PJ, McQuay HJ, Moore RA (2005) Carbamazepine for acute and chronic pain. Cochrane Database Syst Rev CD005451
Woolf CJ, Salter MW (2000) Neuronal plasticity: increasing the gain in pain. Science 288:1765–1769. doi:10.1126/science.288.5472.1765
Yaksh TL (2006) Calcium channels as therapeutic targets in neuropathic pain. J Pain 7:S13–S30. doi:10.1016/j.jpain.2005.09.007
Author information
Authors and Affiliations
Corresponding author
Additional information
This study was conducted as a collaborative trial of the North Central Cancer Treatment Group and Mayo Clinic and was supported in part by Public Health Service grants CA-25224, CA-37404, CA-35103, CA-35119, CA-35415, and CA-35113.
Additional participating institutions include: Medcenter One Health Systems, Bismarck, ND 58501, USA (Edward J. Wos, M.D.); Illinois Oncology Research Assn. CCOP, Peoria, IL 61615-7828, USA (John W. Kugler, M.D.); Abbott Northwestern Hospital, Minneapolis, MN 55407, USA (Daniel M. Anderson, M.D.); Siouxland Hematology–Oncology Associates, Sioux City, IA 51105, USA (Donald B. Wender, M.D.)
Rights and permissions
About this article
Cite this article
Cheville, A.L., Sloan, J.A., Northfelt, D.W. et al. Use of a lidocaine patch in the management of postsurgical neuropathic pain in patients with cancer: a phase III double-blind crossover study (N01CB). Support Care Cancer 17, 451–460 (2009). https://doi.org/10.1007/s00520-008-0542-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-008-0542-x